Amyris Inc. [AMRS] shares are down more than -23.59% this year and recently increased 0.04% or $0.11 to settle at $2.96. Analysts expect AMRS to grow earnings at a 30.00% annual rate over the next 5 years. AMRS has a short ratio of 10.04. This implies that the market is currently less bullish on the outlook for AMRS.

On 23, October 2020, Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5. According to news published on Yahoo Finance, Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the fiscal 2020 third quarter ended September 30, 2020 on Thursday, November 5, 2020. The company plans to hold a conference call and live audio webcast for analysts and investors at 6:00 am Pacific Time (9:00 a.m. Eastern Time).

Analyst Birdseye View:

The most recent analyst activity for Amyris Inc. [NASDAQ:AMRS] stock was on November 14, 2018, when it was Reiterated with a Buy rating from B. Riley FBR, which also lowered its 12-month price target on the stock from $10 to $8. Before that, on December 12, 2019, Oppenheimer Recapitulated an Outperform rating and elevated its amount target to $8. On January 25, 2018, B. Riley FBR Inc. Initiated a Buy rating and boosted its price target on this stock to $8. On May 28, 2014, Stifel Resumed a Hold rating. On February 10, 2012, Deutsche Bank Downgrade a Hold rating and decreased its price target to $9. On November 02, 2011, Robert W. Baird Downgrade a Neutral rating and boosted its amount target on this stock to $16. On January 28, 2011, Stifel Nicolaus Downgrade a Hold rating. Stifel Nicolaus elevated its amount target by recapitulating a higher weight for this stock.

In the past 52 weeks of trading, this stock has oscillated between a low of $1.40 and a peak of $6.07. Right now, according to Wall Street analyst the average 12-month amount target is $10.00. At the most recent market close, shares of Amyris Inc. [NASDAQ:AMRS] were valued at $2.96.


Amyris Inc. [NASDAQ:AMRS] most recently reported quarterly sales of 30.0 billion, which represented growth of -61.10%. This publicly-traded organization’s revenue is $271,938 per employee, while its income is -$419,585 per employee. This company’s Gross Margin is currently 41.90%, its Pretax Margin is -158.72, and its Net Margin is -154.29. Continuing to look at profitability, this corporation’s Return on Assets & Whole Principal is sitting at -162.96 and -658.23 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 754.98 and the whole liability to whole assets at 179.58. It shows enduring liability to the whole principal at 567.20 and enduring liability to assets at 1.35 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 2.73 points at 1st support level, the second support level is making up to 2.60. But as of 1st resistance point, this stock is sitting at 2.92 and at 2.98 for 2nd resistance point.

Amyris Inc. [AMRS] reported its earnings at -$0.56 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.19/share signifying the difference of -0.37 and -194.70% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.56 calling estimates for -$0.19/share with the difference of -0.37 depicting the surprise of -194.70%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Amyris Inc. [NASDAQ:AMRS] is 1.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.00. Now if looking for a valuation of this stock’s amount to sales ratio it’s 2.05.

Insider Stories

The most recent insider trade was by Kung Frank, Director, and it was the purchase of 3.69 million shares on Jun 05. DOERR L JOHN, the Director, completed a purchase of 52785.0 shares on Feb 19. On Feb 19, Melo John, President and CEO, completed a sale of 52875.0 shares.